<DOC>
	<DOCNO>NCT00745186</DOCNO>
	<brief_summary>The purpose study evaluate pharmacokinetics pharmacodynamic bioequivalence safety Hospira Glucagon Injection GlucaGen® healthy volunteer .</brief_summary>
	<brief_title>Pharmacokinetics ( PK ) Pharmacodynamics ( PD ) Mayne Glucagon Injection Compared With Glucagen® ( Novo Nordisk ) Healthy Volunteers</brief_title>
	<detailed_description>Glucagon show effective treatment hypoglycemia , low blood sugar level , patient diabetes . It primarily function counter-regulatory hormone oppose action insulin maintain blood glucose level . A major problem diabetic patient hypoglycemia development defective counter regulatory response include reduced absent glucagon response hypoglycemia . Mayne Glucagon Injection develop alternative currently market product . Administration exogenous glucagon i.e. , produce body , show effective treatment low blood sugar patient diabetes . Mayne develop product , Glucagon Injection , alternative currently market product . The difference source active ingredient . The formulation , rout administration , dosage regimen indication Mayne Glucagon Injection identical currently register market product . A total 28 healthy volunteer recruit study one investigational site .</detailed_description>
	<mesh_term>Hypoglycemia</mesh_term>
	<mesh_term>Glucagon</mesh_term>
	<mesh_term>Glucagon-Like Peptide 1</mesh_term>
	<criteria>Healthy Male female age 1850 year inclusive Body weight 50 100 kg body mass index ( BMI ) 18 30 kg/m2 , outside range , consider clinically significant investigator Nonsmokers exsmokers smoke previous 3 month Written inform consent give Willing able comply requirement protocol available plan duration study Subject must agree use adequate method contraception study 12 week last dose investigational medicinal product ( IMP ) . Adequate method contraception subject partner include condom spermicide gel , diaphragm spermicide gel , coil ( intrauterine device ) , surgical sterilisation , subdermal implant , vasectomy , oral contraceptive pill , depot progesterone injection abstinence . If volunteer usually sexually active becomes active he/she partner must use one contraceptive method list . Male subject whose partner child bear potential must ensure partner use effective contraception course study 12 week thereafter History presence clinically significant finding , opinion investigator , would preclude inclusion study History presence clinical significant gastrointestinal pathology symptom , liver kidney disease condition might interfere absorption , distribution , metabolism excretion drug . Any clinically significant laboratory finding Clinically significant abnormality 12lead electrocardiogram ( ECG ) result Positive pregnancy test lactation Participation clinical study use investigational product device within previous 12 week Positive human immunodeficiency virus ( HIV ) , Hepatitis B C test History drug alcohol abuse within past two year alcohol consumption great 21 unit per week male great 14 unit per week female Blood donation ≥ 500 mL previous 12 week Hypersensitivity Glucagon and/or excipients Use prescription medicine St John 's Wort previous 2 week . The use overthecounter medicine within 5 day dose except deem investigator interfere outcome study . Vitamins , mineral nutritional supplement may take discretion investigator . Hormonal contraceptive permit .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>June 2015</verification_date>
</DOC>